Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06030063 · ClinicalTrials.gov registry record
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
A clinical trial of Cesarean Delivery and General Anesthesia, sponsored by Yale University.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 20
- Study locations
NCT06030063: Recruiting study of Cesarean Delivery and General Anesthesia, sponsored by Yale University.
NCT06030063 is a study of Cesarean Delivery and General Anesthesia that is actively recruiting participants, run by Yale University. The registered enrollment target is 5,000 participants, above the 2,983-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (68% higher). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06030063, a study of Cesarean Delivery and General Anesthesia, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The SOAP registry is a prospective, multicenter, electronic registry. The goal is to investigate the indications, mode of airway management, predisposing factors, and obstetric and anesthetic outcomes of pregnant patients who receive general anesthesia for cesarean delivery.
Primary Outcome
The rates of general anesthesia for cesarean delivery among the institutions in the cohort will be assessed. Descriptive analyses of etiologies of and management of general anesthetics for cesarean delivery will also be performed.
Conditions Studied
Study Locations (20)
Massachusetts
- Brigham & Women's Hospital - Boston
- Boston Medical Center - Boston
- Beth Israel Deaconess Medical Center - Boston
California
- University of California San Francisco - San Francisco
- Stanford University - Stanford
Arkansas
- University of Arkansas - Little Rock
Colorado
- University of Colorado Hospital - Arvada
Connecticut
- Yale University - New Haven
Florida
- University of Florida - Gainesville
Idaho
- St Lukes Anesthesia Associates of Boise - Boise
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-02-22 |
| Est. Completion | 2028-12 |
What NCT06030063 shows while recruiting
NCT06030063 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,983-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (68% higher).
The record links to 2 conditions, with Cesarean Delivery appearing as the primary indexed condition, and to 0 interventions.
NCT06030063 names 20 study sites across 17 states, led by Massachusetts, California, Arkansas.
Frequently Asked Questions
What is clinical trial NCT06030063 about?
NCT06030063 is a clinical study titled "The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry". The SOAP registry is a prospective, multicenter, electronic registry. The goal is to investigate the indications, mode of airway management, predisposing factors, and obstetric and anesthetic outcomes of pregnant patients who receive general anesthesia for cesarean delivery.
What is the current status of trial NCT06030063?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2024-02-22. Estimated completion is 2028-12.
What conditions does trial NCT06030063 study?
This clinical trial studies the following conditions: Cesarean Delivery, General Anesthesia.
Who is sponsoring clinical trial NCT06030063?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06030063 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Delivery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06030063's enrollment target sits among peer trials
5,000 3rd of 10 higher than 8 of 10 other Cesarean Delivery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Delivery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-Operative Cesarean Section Cosmesis
RECRUITING · NA
-
COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block
RECRUITING · Phase 4
-
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
RECRUITING · Phase 4
-
Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin
RECRUITING · NA
-
Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial
RECRUITING · Phase 3
-
IC-CS Risk: Patient Outcomes
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI